Article Text

Download PDFPDF

803 Plasmacytoid Dendritic Cells are Not Major Producers of Type 1 Interferons in Cutaneous Lupus
  1. Thomas Vazquez,
  2. Nilesh Kodali,
  3. DeAnna Diaz,
  4. Jay Patel,
  5. Emily Keyes,
  6. Grant Sprow,
  7. Meena Sharma,
  8. Mariko Ogawa-Momohara,
  9. Madison Grinnell,
  10. Josh Dan and
  11. Victoria P Werth
  1. Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA


Background Type 1 interferons (IFN-1) are major drivers of disease activity in systemic (SLE) and cutaneous lupus erythematosus (CLE). Plasmacytoid dendritic cells (pDCs) are the major producers of IFN-1 during viral infection. Therefore, pDCs have been hypothesized to be the primary IFN-1 producing cell in lupus. IFN-1 production by pDCs has not been extensively studied due to reliance on interferon gene signatures as a proxy for IFN-1 levels as well as a reliance on pDCs from healthy controls for in vitro studies. However, it has been known that pDCs are reduced in the circulation in SLE and have also been more recently shown to have an exhausted phenotype, suggesting that pathogenic pDCs may be located in the end organs.

Methods Well characterized CLE patients were recruited from a prospective database. We performed imaging mass cytometry on archived treatment naïve CLE skin (n=48) and a subset were also used for mRNA in situ hybridization. Fresh 4mm punch biopsies (n=3) and blood (n=4) were obtained from CLE patients and healthy controls (n=3) for multiplexed flow cytometry or cytometry by time of flight (CyTOF).

Results In lesional CLE skin, only 8.5% (IQR 0.0-22.22) of pDCs were IFNα+ (figure 1A,B). Across all CLE biopsies, pDCs were the second lowest contributor of absolute IFNα+ cells (Median 1; IQR 0-4.5), with B lymphocytes being the smallest contributor. Classic dendritic cells (cDCs) and macrophages (Mφ) were the largest relative and absolute contributors of IFNα in CLE (figure 1C). For IFNβ, only 16.7% of pDCs were positive, compared to 60.7% of CD14+CD16+ Mφ. pDCs were also the second lowest contributors of IFNβ+ cells (Median 1; IQR 0-7), with B lymphocytes again being the lowest (figure 1D). For IFNκ, the largest contributor was CD68 Mac, CD14+CD16+ Mac, and cDCs (figure 1E). IFN-1 mRNA was detected in ITGAX (CD11c) positive cDCs but we did not identify colocalization of pDC- specific gene, CLEC4C (BDCA2), and IFN-1 mRNA (figure 2). Flow cytometry on leukocytes eluted from fresh lesional biopsies showed a median of 5.2% of pDCs were positive for IFNα (IQR 3.85 – 9.64) which was significantly lower than the median of 37.9% of HC PBMC pDCs (34.5 – 39.8) (p<0.0001). In comparison, other leukocytes in CLE skin displayed greater positivity for IFNα such as CD4 T cells (Median, IQR) (24.5%, 10.2 – 29), CD14+ cells (17.6%, 10.7 – 23.1), Classical Monocytes (CD14++CD16-) (11.4%, 10.2 – 20.2), Intermediate Monocytes (CD14++CD16+) (13.7%, 12.4 – 17.5), CD68+ Macrophages (24.6%, 10.9 – 32.4), M1 Macrophages (CD68+CD163-) (23.7%, 21.6 – 31.7), M2 Macrophages (CD68+CD163+) (35.9%, 26.4 – 40.7), and CD16+ cells (25.7%, 20.4 – 29.5) (figure 3). Further verification using a Z-axis overlay of intracellular markers on tSNE plots of immune cell clusters identified by CyTOF confirmed low expression of IFN-1and the interferogenic pathway, phosphorylated stimulator of interferon genes (pSTING), in the pDCs (figure 2B).

Conclusions Taken together, these findings suggest pDCs may not play the central role in CLE as major IFN-1 producers and myeloid cells are larger contributors of IFN-1 in numbers and as a percent. pDCs may have a pathogenic role in CLE through IFN-1-independent mechanisms.

Abstract 803 Figure 1

A) IFNα+ Percent of Parent for cell types identified in CLE skin shown in order of descending absolute contribution of IFNα+ cell counts in CLE. 12.83% of pDCs are positive for IFNα. B) Composition of IFNα+ cells (absolute counts) across all aggregated CLE biopsies. C) Weighted (cell count x MPI) IFNα expression. D) Weighted IFNβ expression. E) Weighted IFNκ expression with myeloid lineage consisting of CD68 Mac, CD14+CD16+ Mac, and cDCs revealing dominant IFN-1 contribution from myeloid cells followed by keratinocytes.

Abstract 803 Figure 2

A) Representative images of mRNA in situ hybridization of IFNα and IFNβ mRNA with markers for conventional dendritic cells (ITGAX) and plasmacytoid dendritic cells (CLEC4C). No observable overlap of type 1 interferon mRNA and CLEC4C was seen. B) tSNE plot of PBMCs from a CLE patient stained and acquired by CyTOF. Plasmacytoid dendritic cells, identified principally on CD123 expression, demonstrate little type 1 interferon staining as well as activation of the STING pathway (a signaling molecule upstream of type 1 interferon transcription) on the Z axis.

Abstract 803 Figure 3

Flow cytometry of leukocytes eluted from CLE skin demonstrating significantly fewer IFNα+ plasmacytoid dendritic cells (pDCs) in cutaneous lupus erythematosus (CLE) skin (Median 5.2%, p<0.0001) and peripheral blood mononuclear cells (PBMCs) (12.7%, p<0.0001) than healthy control PBMCs (37.9%). Abbreviations: cDC: classical dendritic cell; pDC: plasmacytoid dendritic cell; moDC: monocyte derived dendritic cell; cM: classical monocyte; intM: intermediate monocyte; ncM: nonclassical monocyte; Mf: macrophage.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: .

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.